• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab.

作者信息

Moon Ji Young, Jo Deog-Yeon, Lee So Yeon, Kim Deok Yeong, Baek Seung-Woo, Song Ik-Chan

机构信息

Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea.

出版信息

Blood Res. 2017 Dec;52(4):337-339. doi: 10.5045/br.2017.52.4.337. Epub 2017 Dec 26.

DOI:10.5045/br.2017.52.4.337
PMID:29333418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5762752/
Abstract
摘要

相似文献

1
Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab.低剂量泼尼松龙用于阵发性夜间血红蛋白尿且对依库珠单抗反应不佳的患者。
Blood Res. 2017 Dec;52(4):337-339. doi: 10.5045/br.2017.52.4.337. Epub 2017 Dec 26.
2
Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.小分子因子 D 抑制剂可选择性阻断阵发性夜间血红蛋白尿和非典型溶血尿毒症综合征中补体的替代途径。
Haematologica. 2017 Mar;102(3):466-475. doi: 10.3324/haematol.2016.153312. Epub 2016 Nov 3.
3
Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.依库珠单抗用于治疗阵发性夜间血红蛋白尿患者。
Cochrane Database Syst Rev. 2014 Oct 30(10):CD010340. doi: 10.1002/14651858.CD010340.pub2.
4
A patient with paroxysmal nocturnal hemoglobinuria being treated with eculizumab who underwent laparoscopic cholecystectomy: report of a case.一名接受依库珠单抗治疗的阵发性夜间血红蛋白尿患者接受了腹腔镜胆囊切除术：病例报告。
Surg Case Rep. 2015;1(1):57. doi: 10.1186/s40792-015-0059-8. Epub 2015 Jul 11.
5
[Management of paroxysmal nocturnal hemoglobinuria: an update].[阵发性睡眠性血红蛋白尿的管理：最新进展]
Rinsho Ketsueki. 2018;59(6):703-710. doi: 10.11406/rinketsu.59.703.
6
[Rare case of a pregnancy in a woman with paroxysmal nocturnal hemoglobinuria. Case report].[阵发性夜间血红蛋白尿症女性患者妊娠的罕见病例。病例报告]
Orv Hetil. 2016 Jun 5;157(23):916-8; quiz 919-20. doi: 10.1556/650.2016.30430.
7
Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.接受依库珠单抗治疗的阵发性睡眠性血红蛋白尿症患者的妊娠结局：日本经验及最新综述
Int J Hematol. 2016 Jun;103(6):703-12. doi: 10.1007/s12185-016-1946-x. Epub 2016 Feb 8.
8
Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report.依库珠单抗成功治疗阵发性夜间血红蛋白尿所致非肝硬化门静脉高压症：一例报告
World J Hepatol. 2019 May 27;11(5):483-488. doi: 10.4254/wjh.v11.i5.483.
9
[Successful pregnancy and delivery achieved with eculizumab administration initiated after a preceding missed abortion in a patient with paroxysmal nocturnal hemoglobinuria].阵发性夜间血红蛋白尿患者在前次稽留流产后开始使用依库珠单抗治疗并成功妊娠及分娩
Rinsho Ketsueki. 2019;60(4):281-285. doi: 10.11406/rinketsu.60.281.
10
Ten Years of Clinical Experience With Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria.阵发性睡眠性血红蛋白尿症患者使用依库珠单抗的十年临床经验。
Semin Hematol. 2018 Jul;55(3):124-129. doi: 10.1053/j.seminhematol.2018.04.001. Epub 2018 Apr 9.

引用本文的文献

1
Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in Asia.改善亚洲难治性或复发性弥漫性大B细胞淋巴瘤患者获得嵌合抗原受体T细胞治疗的机会。
Discov Oncol. 2025 Feb 14;16(1):181. doi: 10.1007/s12672-025-01860-5.
2
Molecular insights into hereditary elliptocytosis and pyropoikilocytosis: NGS uncovers multiple potential candidate genes.遗传性椭圆形红细胞增多症和热不稳定血红蛋白血症的分子见解：NGS 揭示多个潜在候选基因。
Ann Hematol. 2023 Sep;102(9):2343-2351. doi: 10.1007/s00277-023-05337-9. Epub 2023 Jul 4.

本文引用的文献

1
Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.评估接受依库珠单抗治疗的阵发性睡眠性血红蛋白尿症患者的补体阻断情况。
Blood. 2015 Jan 29;125(5):775-83. doi: 10.1182/blood-2014-03-560540. Epub 2014 Dec 4.
2
Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena.依库珠单抗治疗阵发性睡眠性血红蛋白尿症患者的慢性治疗：安全性、疗效和意外的实验室现象。
Int J Hematol. 2011 Jun;93(6):704-714. doi: 10.1007/s12185-011-0867-y. Epub 2011 May 25.
3
Management of paroxysmal nocturnal haemoglobinuria: a personal view.阵发性睡眠性血红蛋白尿症的治疗：个人观点。
Br J Haematol. 2011 Jun;153(6):709-20. doi: 10.1111/j.1365-2141.2011.08690.x. Epub 2011 Apr 22.
4
Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.依库珠单抗长期治疗阵发性睡眠性血红蛋白尿症：疗效持续且生存改善。
Blood. 2011 Jun 23;117(25):6786-92. doi: 10.1182/blood-2011-02-333997. Epub 2011 Apr 1.
5
Paroxysmal nocturnal hemoglobinuria--hemolysis before and after eculizumab.阵发性夜间血红蛋白尿——依库珠单抗治疗前后的溶血情况
N Engl J Med. 2010 Dec 2;363(23):2270-2. doi: 10.1056/NEJMc1010351.
6
Hemolytic anemia after eculizumab in paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿患者使用依库珠单抗后的溶血性贫血。
N Engl J Med. 2010 Sep 2;363(10):993-4. doi: 10.1056/NEJMc1005108.
7
How I treat paroxysmal nocturnal hemoglobinuria.我如何治疗阵发性夜间血红蛋白尿症。
Blood. 2009 Jun 25;113(26):6522-7. doi: 10.1182/blood-2009-03-195966. Epub 2009 Apr 16.
8
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.阵发性睡眠性血红蛋白尿症患者接受依库珠单抗治疗时，红细胞上补体C3片段结合作为疾病的附加机制。
Blood. 2009 Apr 23;113(17):4094-100. doi: 10.1182/blood-2008-11-189944. Epub 2009 Jan 29.
9
Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab.接受依库珠单抗治疗的阵发性夜间血红蛋白尿患者脾切除术后血红蛋白恢复正常
Blood. 2008 Jul 15;112(2):449-51. doi: 10.1182/blood-2008-04-151613.
10
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.补体抑制剂依库珠单抗对阵发性夜间血红蛋白尿患者血栓栓塞的影响。
Blood. 2007 Dec 1;110(12):4123-8. doi: 10.1182/blood-2007-06-095646. Epub 2007 Aug 16.